Clinical Trial Update: Safety And PK Study Of CVX-060 In Patients With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 safety and pharmacokinetic study of CVX-060 in patients with advanced solid tumors has completed and results are posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• CVX-060

Snippet

Sponsor: Pfizer | Conditions: Advanced Solid Tumors, Neoplasms | Phase 1 | Status: COMPLETED | Results posted: 2015-01-26